Status:
COMPLETED
Assessment of CAI in Adults With PWS.
Lead Sponsor:
Medical University of Warsaw
Conditions:
Central Adrenal Insufficiency
Prader-Willi Syndrome
Eligibility:
All Genders
18-26 years
Brief Summary
Introduction: The prevalence and clinical significance of central adrenal insufficiency (CAI) in adult patients with Prader Willi Syndrome (PWS) remains unclear. Aim: To assess the prevalence of CAI ...
Eligibility Criteria
Inclusion
- PWS
- age \>=18 years
Exclusion
- age \<18 years
- GC treatment at last 6 months
Key Trial Info
Start Date :
May 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2020
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04700644
Start Date
May 15 2020
End Date
June 6 2020
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Clinical Hospital Medical University of Warsaw
Warsaw, Poland, 02-097